Linked by Thom Holwerda on Mon 12th Mar 2012 19:04 UTC
Legal "Patent monopolies prevent innovation. It is a system that works against innovations, to protect the current corporations against competition from aggressive, innovative, and competitive upstarts. It allows the big corporations to crush competitive upstarts in the courtroom, rather than having to compete with their products and services." ...which happens to be exactly why the old boys' club of computer technology (Apple, Microsoft, Oracle, IBM) wants to keep it this way. This is not a system for the people, it's a system for huge corporations.
Thread beginning with comment 510420
To view parent comment, click here.
To read all comments associated with this story, please click here.
RE[2]: A first hand experience
by wannabe geek on Tue 13th Mar 2012 16:52 UTC in reply to "RE: A first hand experience"
wannabe geek
Member since:

Without some sort of exclusivity, it would be foolish for any company to spend the dollars needed to develop pharmaceuticals as they would never get their investment back out as others copied for less and saturate the market.

It would work in a different way. Those who are interested in the potential of new medicines would probably fund the research. Patients and their families would more often be stockholders. There would be many kinds of contracts, for instance with a floor salary for researchers and a bonus for actual achievements.

Or maybe the research would be funded by health insurance companies, who knows. In general we can't predict how future (free) markets will develop, but we can predict that they will clear.

Reply Parent Score: 3